Võrdle meetodeid

	Positiivse ja negatiivse afekti skaala (PANAS)	Hamiltoni ärevuse hindamise skaala (HAM-A)	Haigla Ärevuse ja Depressiooni Skaala (HADS)
Valdkond	Kliiniline psühholoogia	Kliiniline psühholoogia	Kliiniline psühholoogia
Perekond	Process / pipeline	Process / pipeline	Process / pipeline
Tekkeaasta	1988	1959	1983
Looja	David Watson, Lee Anna Clark, and Auke Tellegen	Max Hamilton	Andrew S. Zigmond and Richard P. Snaith
Tüüp	Mood and affect self-assessment	Clinician-administered anxiety assessment	Anxiety and depression screening in medical populations
Algallikas	Watson, D., Clark, L. A., & Tellegen, A. (1988). Development and validation of brief measures of positive and negative affect: The PANAS scales. Journal of Personality and Social Psychology, 54(6), 1063-1070.	Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32(1), 50-55.	Zigmond, A. S., & Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67(6), 361-370.
Rööpnimetused	PANAS, PANAS-X	HAM-A, HARS	HADS, HADS-A, HADS-D
Seotud	5	5	4
Kokkuvõte	The Positive and Negative Affect Schedule (PANAS) is a brief, efficient self-report measure of mood and emotional affect. Developed by Watson, Clark, and Tellegen in 1988, it assesses two independent dimensions: positive affect (enthusiasm, attentiveness, interest) and negative affect (distress, anxiety, anger). The 20-item standard version is one of the most widely used instruments for measuring emotion in research and clinical contexts.	The Hamilton Anxiety Rating Scale (HAM-A) is a clinician-administered assessment tool for quantifying the severity of anxiety symptoms in adults. Developed by Max Hamilton in 1959, it remains one of the most widely used instruments for evaluating anxiety in clinical and research settings. The scale measures both psychological and somatic manifestations of anxiety across 14 items.	The Hospital Anxiety and Depression Scale (HADS) is a 14-item self-report instrument measuring anxiety and depression symptoms in medically ill populations. Developed by Zigmond and Snaith in 1983, the HADS was specifically designed for hospital and general medical settings where somatic symptoms of medical illness may confound assessment. It remains the standard anxiety-depression measure in medical, oncology, and cardiac populations worldwide.